CMS-2T2-25-001: Section 206 of the Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid and CHIP Beneficiaries Following Incarceration
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Center for Medicare and Medicaid Services notices from 2024.
Center for Medicare and Medicaid Services offered grants of up to $5.0 million to state and local governments. It expected to make about 56 awards worth $107 million in total. Applications closed on April 18, 2025.
From the official notice on Grants.gov, last changed March 13, 2025. Checked November 7, 2026.
- Award ceiling$5.0 million
- Total funding$107 million
- Expected awards56
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | September 27, 2024 |
|---|---|
| Deadline | April 18, 2025 |
| Archived by Grants.gov | March 17, 2026 |
Who can apply
This opportunity was open to state and local governments.
- State governments
State governments, District of Columbia, and territorial governments, specifically Medicaid and CHIP agencies. The term “state Medicaid agency” means the single state agency for medical assistance provided under Title XIX of the Social Security Act (the Act), while the term “state CHIP agency” means the state agency responsible for administering the state CHIP plan under Title XXI of the Act. Further, if a state administers its Medicaid and CHIP programs through separate agencies, both agencies must agree to work together and submit one application per state. For the purposes of this NOFO and to align efforts, states with separate Medicaid and CHIP programs must include in their single application a letter of agreement identifying the Authorized Organizational Representative (AOR), the lead agency, and plans for collaboration. A Tribal organization must come under the auspices of and work with the state Medicaid and CHIP agency (or agencies, if separate) in the implementation of this initiative.
Is this a realistic fit?
- Past Section 206 Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid & CHIP Beneficiaries awards averaged $1.3 million; this notice allows up to $5.0 million per award.
- Most of the program's money (100% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
The Centers for Medicare & Medicaid Services (CMS) is seeking applications from eligible state Medicaid and CHIP agencies for planning grants to develop operational capabilities to promote continuity of care for individuals who meet both of the following criteria: •Are inmates of a public institution, and •Are eligible for medical assistance under the state Medicaid program or are eligible for child health assistance or pregnancy-related assistance under the state Children’s Health Insurance Program (CHIP). These planning grants also support states with operationalizing requirements under section 205 of division G of the CAA, 2024 (P.L. 118-42), as well as the CAA, 2023 (P.L. 117-328). Funds may be used for addressing operational barriers and improving systems for continuity of care following incarceration in state-operated prisons, local, tribal, and county jails, and youth correctional or detention facilities. CMS will fund cooperative agreements for a four-year period of performance.
Who has won Section 206 Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid & CHIP Beneficiaries grants before
From fiscal 2021 to 2025, Section 206 Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid & CHIP Beneficiaries (93.694) awarded $38.7 million across 29 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| VA Department of Medical Assistance Service | Virginia | 1 | $3.0 million |
| Oklahoma Health Care Authority | Oklahoma | 1 | $2.7 million |
| PA Department of Human Services | Pennsylvania | 1 | $2.6 million |
| New Mexico Health Care Authority | New Mexico | 1 | $2.5 million |
| State of Alaska Department of Health | Alaska | 1 | $1.7 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CMS-2T2-25-001 still open?
No. It closed on April 18, 2025.
Who can apply for Section 206 of the Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid and CHIP Beneficiaries Following Incarceration?
Center for Medicare and Medicaid Services accepted applications from state and local governments. The notice adds further conditions, so read its eligibility section.
What is the deadline for Section 206 of the Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid and CHIP Beneficiaries Following Incarceration?
Closed April 18, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $5.0 million each. About $107 million in total across about 56 awards.
Who has won Section 206 Consolidated Appropriations Act, 2024: State Planning Grants to Promote Continuity of Care for Medicaid & CHIP Beneficiaries grants before?
The largest recipients over five fiscal years were VA Department of Medical Assistance Service, Oklahoma Health Care Authority, PA Department of Human Services. The program made 29 awards worth $38.7 million in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)